
The Ron Lanton Report: From Innovation to Infrastructure
In this episode, Ron Lanton draws on insights from the JP Morgan Healthcare Conference to explain how healthcare investment is shifting from backing novel ideas to funding organizations that can scale, survive regulatory and reimbursement pressure, and embed technology into the operational infrastructure of care delivery.
This episode of The Ron Lanton Report examines how healthcare investment is shifting from funding novel technologies to backing the organizations most likely to turn those technologies into durable infrastructure. Using insights from the JP Morgan Healthcare Conference as a starting point, the episodes discussion reframes the investment narrative away from headline-grabbing deals and toward the quieter, structural questions that shape what actually gets built. Instead of simply asking whether an idea is innovative, capital is increasingly asking whether it can be executed, scaled, and embedded into the day-to-day operations of healthcare.
The conversation is organized around three questions that now appear to guide many investment decisions: can it scale, can it survive, and can it become infrastructure? On scalability, Lanton highlights that healthcare has never lacked promising concepts; the bottleneck is moving from pilots to operational businesses with credible paths to commercialization and sustainable growth. Investors are concentrating capital in companies that can demonstrate operational maturity, commercial readiness, and realistic growth trajectories, rather than diffuse portfolios of early ideas that may never turn into functioning enterprises.
From there, the analysis turns to survivability and infrastructure. Investors are placing greater emphasis on how organizations perform under reimbursement pressure, regulatory change, and volatile operating conditions, treating risk and resilience as central to underwriting decisions.
At the same time, interest is converging on technologies and services, such as AI, diagnostics, remote monitoring, and care coordination, that can be woven directly into workflows, workforce support, and administrative functions. The core thesis is that innovation still matters, but the terms on which it is evaluated have changed: the organizations most likely to attract capital are those that can operationalize technology, integrate into healthcare’s core infrastructure, and create durable value over time.




